Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Britannia Life Sciences, Inc. ?
1
The company has declared Negative results for the last 4 consecutive quarters
- NET PROFIT(Q) At CAD -0.14 MM has Fallen at -203.69%
- OPERATING CASH FLOW(Y) Lowest at CAD 1.11 MM
- ROCE(HY) Lowest at -175.45%
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 60.00%, its profits have fallen by -797%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Britannia Life Sciences, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Britannia Life Sciences, Inc.
80.0%
0.15
221.71%
S&P/TSX 60
19.1%
1.43
14.72%
Quality key factors
Factor
Value
Sales Growth (5y)
41.83%
EBIT Growth (5y)
15.22%
EBIT to Interest (avg)
-1.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
4.92
Sales to Capital Employed (avg)
0.66
Tax Ratio
3.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.09%
ROE (avg)
4.44%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.76
EV to EBIT
10.85
EV to EBITDA
10.85
EV to Capital Employed
9.80
EV to Sales
1.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.97%
ROE (Latest)
-48.16%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Britannia Life Sciences, Inc.
Pre-Tax Profit
Highest at CAD 0.14 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Debtors Turnover Ratio
Highest at 5.89%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Britannia Life Sciences, Inc.
Net Profit
At CAD -0.14 MM has Fallen at -203.69%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CAD MM)
Operating Cash Flow
Lowest at CAD 1.11 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CAD MM)
Debt-Equity Ratio
Highest at 512.02 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 17.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






